Tenet Healthcare (THC) Tops Q2 EPS by 4c
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $1.11, $0.04 better than the analyst estimate of $1.07. Revenue for the quarter came in at $4.1 billion versus the consensus estimate of $4.78 billion.
GUIDANCE:
Tenet Healthcare sees FY2021 EPS of $5.23-$5.73 vs consensus of $4.35-$5.67.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
